$11.1M in expenses

During the reporting year, the organization advanced its enterprise-wide quality and operational infrastructure through several key initiatives. The ISO 9001:2015 certification was successfully renewed and extended to the GenCure site, reinforcing alignment across the Quality Management System and ensuring consistent standards across manufacturing, testing, and clinical operations. A full GMP compliance audit was also completed, verifying adherence to FDA regulations and confirming cGMP readiness across bioproduction and testing facilities. The organization also advanced its quality assurance framework through successful execution of process validation and system qualification activities. These efforts ensured that critical production and testing systems operate consistently within defined parameters, supporting product integrity and regulatory compliance. By validating key processes and qualifying (Continued on Schedule O)